ahlam1399
04-06-2016, 01:17 AM
Exclusive: Pfizer leaning toward abandoning deal with Allergan ? source
(Reuters) - Drugmaker Pfizer Inc is leaning toward abandoning its $160 billion agreement to buy Allergan Plc in light of the U.S. Treasury's new measures to curb such tax evading deals, a source familiar with the situation said on Tuesday.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654200/s/4ebdbd84/sc/24/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/topNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/topNews?a=yIFxWPAyXxY:GuicFURp4v8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/topNews?i=yIFxWPAyXxY:GuicFURp4v8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/topNews?a=yIFxWPAyXxY:GuicFURp4v8:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/topNews?i=yIFxWPAyXxY:GuicFURp4v8:-BTjWOF_DHI (http://feeds.reuters.com/~ff/reuters/topNews?a=yIFxWPAyXxY:GuicFURp4v8:-BTjWOF_DHI)
http://feeds.feedburner.com/~r/reuters/topNews/~4/yIFxWPAyXxY
(Reuters) - Drugmaker Pfizer Inc is leaning toward abandoning its $160 billion agreement to buy Allergan Plc in light of the U.S. Treasury's new measures to curb such tax evading deals, a source familiar with the situation said on Tuesday.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654200/s/4ebdbd84/sc/24/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/topNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/topNews?a=yIFxWPAyXxY:GuicFURp4v8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/topNews?i=yIFxWPAyXxY:GuicFURp4v8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/topNews?a=yIFxWPAyXxY:GuicFURp4v8:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/topNews?i=yIFxWPAyXxY:GuicFURp4v8:-BTjWOF_DHI (http://feeds.reuters.com/~ff/reuters/topNews?a=yIFxWPAyXxY:GuicFURp4v8:-BTjWOF_DHI)
http://feeds.feedburner.com/~r/reuters/topNews/~4/yIFxWPAyXxY